One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of Contents
doi : 10.1016/S0039-6257(23)00058-9
Volume 68, Issue 3, May–June 2023, Pages A2-A4
The role of near-infrared reflectance imaging in retinal disease: A systematic review
Georges Sukkarieh, MD?, Raphaël Lejoyeux, MD, Yannick LeMer, MD, Sophie Bonnin, MD, Ramin Tadayoni, MD, PhD
doi : 10.1016/j.survophthal.2022.12.003
Volume 68, Issue 3, May–June 2023, Pages 313-331
Effects of systemic drugs on the development and progression of age-related macular degeneration
Kara R. Grimes, MS a, Abhilasha Aloney, DBM b, Dimitra Skondra, MD, PhD c, Jay Chhablani, MD
doi : 10.1016/j.survophthal.2023.01.007
Volume 68, Issue 3, May–June 2023, Pages 332-346
Age-related macular degeneration (AMD) is the leading cause of severe loss of central vision among people over 50. The pathophysiology of the disease is multifactorial and can be attributed to genetics, aging, inflammation, environmental factors, and lifestyle factors including smoking, diet, obesity, and alcohol consumption. While there is no treatment for dry AMD, the current standard treatment for wet AMD is an intraocular injection of anti-vascular endothelial growth factor—an effective, yet expensive, therapy that requires ongoing treatment.
Typical and atypical clinical presentations of X-Linked retinoschisis: A case series and literature review
Taku Wakabayashi, MD, PhD a, Emmanuel Chang, MD, PhD b, Eric Nudleman, MD, PhD c, Ehab N El-Rayes, MD, PhD d,e, Yoshihiro Yonekawa, MD
doi : 10.1016/j.survophthal.2023.01.008
Volume 68, Issue 3, May–June 2023, Pages 347-360
X-linked retinoschisis (XLRS) is an X-linked inherited retinal dystrophy characterized by mild-to-severe visual impairment, splitting of the retinal layers, and a reduction in the dark-adapted b-wave amplitude on the electroretinogram. Typical clinical features include macular and peripheral schisis.
Vitelliform maculopathy: Diverse etiologies originating from one common pathway
Claudio Iovino, MD a, Prithvi Ramtohul, MD b, Adrian Au, MD, PhD c, Veronica Romero-Morales, MD c, SriniVas Sadda, MD d,e, K Bailey Freund, MD b,f, David Sarraf, MD
doi : 10.1016/j.survophthal.2023.01.009
Volume 68, Issue 3, May–June 2023, Pages 361-379
Vitelliform lesions (VLs) are associated with a wide array of macular disorders but are the result of one common pathway: retinal pigment epithelium (RPE) impairment and phagocytic dysfunction.
Retinal ischemic cascade: New insights into the pathophysiology and imaging findings
Seyed-Hossein Abtahi, MD a,b,#, Ramin Nourinia, MD a,b,#, Mehdi Mazloumi, MD, MPH c, Hosein Nouri, MD a, J. Fernando Arevalo, MD, PhD, FACS d,?, Hamid Ahmadieh, MD
doi : 10.1016/j.survophthal.2022.11.009
Volume 68, Issue 3, May–June 2023, Pages 380-387
Retinal ischemia gives rise to a complex spectrum in which the cumulative profile of ischemia of the middle and inner retina can be highly variable. We reviewed the current knowledge on paracentral acute middle maculopathy (PAMM) pathophysiology and accompanying risk factors, the middle and inner retinal vasculature and blood flow, and the vulnerability of the middle retina in vaso-occlusive disorders.
The natural history of untreated ocular hypertension and glaucoma
Amelien Lauwers, MD a,1, Jo?o Barbosa Breda, MD, PhD b,c,d,1,?, Ingeborg Stalmans, MD, PhD
doi : 10.1016/j.survophthal.2022.12.001
Volume 68, Issue 3, May–June 2023, Pages 388-424
Glaucoma is a chronic, progressive disease leading to irreversible blindness if left untreated; however, since reducing intraocular pressure has proven to be successful in slowing disease progression, little is known about the natural history of untreated glaucoma. This knowledge can be valuable in guiding management decisions in the era of personalized medicine.
Prophylactic intraocular pressure lowering measures in anti-vascular endothelial growth factor therapy: A systematic review and meta-analysis
Parnian Arjmand, MD, MSc, FRCSC a, Caberry W. Yu, MD b, Marko M. Popovic, MD, MPH(c) c, Aaditeya Jhaveri e, Efrem D. Mandelcorn, MD, FRCSC
doi : 10.1016/j.survophthal.2022.12.002
Volume 68, Issue 3, May–June 2023, Pages 425-445
Acute intraocular pressure (IOP) elevation following repeat intravitreal anti-vascular endothelial growth factor (VEGF) injections (IVI) may pose a risk to the integrity of the retinal nerve fiber (RNFL). This meta-analysis investigates the role of IOP-lowering interventions such as an anterior chamber paracentesis (ACP) and IOP-lowering medications on the IOP in patients undergoing IVIs.
Stepwise approach for fundus imaging in the diagnosis and management of posterior uveitis
Aniruddha Agarwal, MD a,b,c,?, Francesco Pichi, MD a,c, Alessandro Invernizzi, MD d,e, Dilraj S. Grewal, MD f, Rohan Bir Singh, MD g,h,i, Awaneesh Upadhyay, MD
doi : 10.1016/j.survophthal.2023.01.006
Volume 68, Issue 3, May–June 2023, Pages 446-480
An array of retinochoroid imaging modalities aid in comprehensive evaluation of the immunopathological changes in the retina and choroid, forming the core component for the diagnosis and management of inflammatory disorders such as uveitis.
Orbital and ocular perfusion in thyroid eye disease
Ruchi Goel, FRCOphth a,?, Shalin Shah, MS a, Gangadhara Sundar, FRCSEd b, Ritu Arora, FRCOphth a, Swati Gupta, FRCR c, Tamanna Khullar, MD
doi : 10.1016/j.survophthal.2023.01.003
Volume 68, Issue 3, May–June 2023, Pages 481-506
Thyroid eye disease (TED) is characterized by enlargement of extraocular muscles, an increase in retrobulbar fat, orbital fibrosis, and fluctuations in plasma thyroid hormone levels in most patients, often associated with raised autoantibody titers.
Amblyopia: A review of unmet needs, current treatment options, and emerging therapies
Emmanuel BUI QUOC, MD, PhD a,?, Marjean T. KULP, OD, MS b, James G. BURNS, PhD c, Benjamin THOMPSON, PhD
doi : 10.1016/j.survophthal.2023.01.001
Volume 68, Issue 3, May–June 2023, Pages 507-525
Amblyopia is a global public health issue with extensive, multifaceted impacts on vision and quality of life (QoL) for both patients and families. Geographical variation exists in the management of amblyopia, with traditional mainstay treatments, optical correction, and fellow eye occlusion most successful when implemented at an early age.
Preoperative evaluations for ophthalmic surgery: A systematic review of 48,869 eyes
Verina Hanna, MD a, Marko M. Popovic, MD, MPH(C) b, Sherif El-Defrawy, MD, PhD, FRCSC b,c, Matthew B. Schlenker, MD, MSc, FRCSC b,c, Ravin Alaei, PhD, MD(C) d, Peter J. Kertes, MD, CM, FRCSC
doi : 10.1016/j.survophthal.2022.12.004
Volume 68, Issue 3, May–June 2023, Pages 526-538
Eliminating low-yield testing can reduce the burden on modern health care systems. Our purpose is to determine whether routine preoperative assessment impacts the incidence of perioperative complications in ophthalmic surgery.
The impact of early exposure to general anesthesia on visual and neurocognitive development
Audrey M.B. Wong-Kee-You, PhD a, Cam Loveridge-Easther, MD a,b, Claudia Mueller, MD, PhD c,d, Noah Simon, MD c, William V. Good, MD
doi : 10.1016/j.survophthal.2022.08.006
Volume 68, Issue 3, May–June 2023, Pages 539-555
Every year millions of children are exposed to general anesthesia while undergoing surgical and diagnostic procedures. In the field of ophthalmology, 44,000 children are exposed to general anesthesia annually for strabismus surgery alone. While it is clear that general anesthesia is necessary for sedation and pain minimization during surgical procedures, the possibility of neurotoxic impairments from its exposure is of concern.
Escape from prism
Michael C. Brodsky, MD a,?, Bryce J. Aul, MD b, David J. Daniels, MD, PhD c, Mays El-Dairi, MD
doi : 10.1016/j.survophthal.2022.02.003
Volume 68, Issue 3, May–June 2023, Pages 556-561
A 14-year-old boy with a history of shunted congenital hydrocephalus began having headaches with nausea and vomiting after transcontinental flights. He gradually developed horizontal diplopia indicative of mild bilateral sixth nerve palsy, without papilledema or ventriculomegaly.
Comment on: Retinal displacement following rhegmatogenous retinal detachment: A systematic review and meta-analysis
Ke Nie, MM
doi : 10.1016/j.survophthal.2023.01.004
Volume 68, Issue 3, May–June 2023, Pages 562-563
Response to our article entitled “Retinal displacement following rhegmatogenous retinal detachment: A systematic review and meta-analysis�
Ryan H. Mason, MD, PhD, Samuel A. Minaker, MD, MScSamara B. Marafon, MD, MSc, Natalia Figueiredo, MDRoxane J. Hillier, MBChB, MSc, FRCOPHTHRajeev H. Muni, MD, MSc, FRCSC
doi : 10.1016/j.survophthal.2023.01.005
Volume 68, Issue 3, May–June 2023, Pages 564-565
